TPG GP A’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,020,748
Closed -$2.25M 42
2022
Q2
$2.25M Hold
1,020,748
0.03% 37
2022
Q1
$1.91M Hold
1,020,748
0.02% 39
2021
Q4
$2.23M Buy
+1,020,748
New +$2.76M 0.02% 41

TPG GP A's ETTX Position: Q3 2022 in Review

TPG GP A sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 1,020,748 shares — an estimated $2.25M sold.

TPG GP A first reported a position in ETTX in Q4 2021 and held it in 3 quarters. The position peaked at $2.25M in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • TPG GP A reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • TPG GP A sold 1,020,748 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $2.25M.
  • TPG GP A first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2021 and held it in 3 quarters.
  • TPG GP A's Entasis Therapeutics Holdings Inc. position peaked at $2.25M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on TPG GP A's 13F filing for Q3 2022, filed 14 Nov 2022.